Real-World Effectiveness and Safety of Sofosbuvir-Based Therapy in Chinese Children and Adolescents With Chronic HCV Infection: A Retrospective Multicentre Study. [PDF]
ABSTRACT Few direct‐acting antiviral regimens are approved in China for children and adolescents with chronic hepatitis C virus (HCV) infection and data are limited on their efficacy and safety in this population. This retrospective, multi‐centre study aimed to assess the real‐world effectiveness and safety of ledipasvir/sofosbuvir (LDV/SOF) and ...
Liu L +12 more
europepmc +2 more sources
[Retracted] Cocktail therapy with a combination of interferon, ribavirin and angiotensin‑II type 1 receptor blocker attenuates murine liver fibrosis development. [PDF]
Yoshiji H +8 more
europepmc +1 more source
Adenoviral pneumonia with organising features in an immunocompetent patient: When steroids make the difference. [PDF]
Shrinath V +3 more
europepmc +1 more source
Molnupiravir is effective against hepatitis E virus infection in an animal model. [PDF]
Wu S +21 more
europepmc +1 more source
Unmasking the Threat: Acute Hepatitis E Virus Infection in a Liver Transplant Recipient. [PDF]
Awadallah M +6 more
europepmc +1 more source
Targeted Medical Interventions for the Prevention and Treatment of Viral Hemorrhagic Fever: A Rapid Systematic Review of Updated Intelligence from the 74th Annual Meeting of the American Society of Tropical Medicine and Hygiene. [PDF]
Hawley GD +11 more
europepmc +1 more source
Successful re-infusion of hepatitis E contaminated stem cells during autologous stem cell transplantation with ribavirin prophylaxis. [PDF]
Sadler H +13 more
europepmc +1 more source
Hepatitis C in Chronic Kidney Disease After the DAA Revolution: Clinical Decisions, Transplantation, and Implementation Challenges. [PDF]
Mohrag M +3 more
europepmc +1 more source
Deuremidevir hydrobromide (VV116) is a promising antiviral against human metapneumovirus. [PDF]
Wang H +6 more
europepmc +1 more source
Lassa fever and Argentine hemorrhagic fever treatment in guinea pigs using broad-spectrum cap-dependent endonuclease inhibitors. [PDF]
Maruyama J +18 more
europepmc +1 more source

